Drug Shortage Report for EPINEPHRINE INJECTION USP
Report ID | 76329 |
Drug Identification Number | 02435810 |
Brand name | EPINEPHRINE INJECTION |
Common or Proper name | EPINEPHRINE INJECTION |
Company Name | HIKMA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | EPINEPHRINE |
Strength(s) | 1MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRACARDIAC INTRAMUSCULAR INTRATRACHEAL INTRAVENOUS SUBCUTANEOUS |
Packaging size | 1 ML |
ATC code | C01CA |
ATC description | CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2019-03-04 |
Actual start date | |
Estimated end date | 2019-06-17 |
Actual end date | 2019-06-18 |
Shortage status | Resolved |
Updated date | 2019-06-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 5995 AVEBURY ROAD, SUITE 804 MISSISSAUGA, ONTARIO CANADA L5R 3P9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-02-19 | English | Compare |